Correlation Between Avadel Pharmaceuticals and Sabra Healthcare

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Avadel Pharmaceuticals and Sabra Healthcare at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Avadel Pharmaceuticals and Sabra Healthcare into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Avadel Pharmaceuticals PLC and Sabra Healthcare REIT, you can compare the effects of market volatilities on Avadel Pharmaceuticals and Sabra Healthcare and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Avadel Pharmaceuticals with a short position of Sabra Healthcare. Check out your portfolio center. Please also check ongoing floating volatility patterns of Avadel Pharmaceuticals and Sabra Healthcare.

Diversification Opportunities for Avadel Pharmaceuticals and Sabra Healthcare

-0.22
  Correlation Coefficient

Very good diversification

The 3 months correlation between Avadel and Sabra is -0.22. Overlapping area represents the amount of risk that can be diversified away by holding Avadel Pharmaceuticals PLC and Sabra Healthcare REIT in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sabra Healthcare REIT and Avadel Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Avadel Pharmaceuticals PLC are associated (or correlated) with Sabra Healthcare. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sabra Healthcare REIT has no effect on the direction of Avadel Pharmaceuticals i.e., Avadel Pharmaceuticals and Sabra Healthcare go up and down completely randomly.

Pair Corralation between Avadel Pharmaceuticals and Sabra Healthcare

Given the investment horizon of 90 days Avadel Pharmaceuticals PLC is expected to generate 2.44 times more return on investment than Sabra Healthcare. However, Avadel Pharmaceuticals is 2.44 times more volatile than Sabra Healthcare REIT. It trades about 0.04 of its potential returns per unit of risk. Sabra Healthcare REIT is currently generating about 0.08 per unit of risk. If you would invest  798.00  in Avadel Pharmaceuticals PLC on September 2, 2024 and sell it today you would earn a total of  308.00  from holding Avadel Pharmaceuticals PLC or generate 38.6% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Avadel Pharmaceuticals PLC  vs.  Sabra Healthcare REIT

 Performance 
       Timeline  
Avadel Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Avadel Pharmaceuticals PLC has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's fundamental indicators remain quite persistent which may send shares a bit higher in January 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Sabra Healthcare REIT 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Sabra Healthcare REIT are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Sabra Healthcare may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Avadel Pharmaceuticals and Sabra Healthcare Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Avadel Pharmaceuticals and Sabra Healthcare

The main advantage of trading using opposite Avadel Pharmaceuticals and Sabra Healthcare positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Avadel Pharmaceuticals position performs unexpectedly, Sabra Healthcare can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sabra Healthcare will offset losses from the drop in Sabra Healthcare's long position.
The idea behind Avadel Pharmaceuticals PLC and Sabra Healthcare REIT pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Other Complementary Tools

Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years